Beth Israel Deaconess Plymouth
FIRESIDE CHAT 10/19/2021 REPLAY. LIMITED TO PROFESSIONAL INVESTORS AND CLIENTS OF MAXIM.
10/19/2021 REPLAY
SENSUS HEALTHCARE TO PARTICIPATE AT H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE
SEP 13, 20217:00AM EDT
ROTH CAPITAL MARKETS PANEL DISCUSSION: FLIPPING THE SWITCH TO PROFITABILITY
MAR 16, 202110:00 AM EDT
The SRT-100+™—a state-of-the art system that is transforming the lives of people coping with non-melanoma skin cancer and unsightly keloid scars has been developed by Sensus Healthcare. This machine harnesses the remarkable healing power of Superficial Radiation Therapy to achieve remarkable results.
Designed with patients and physicians in mind, the SRT-100+™ is compact, mobile, and easy to use. Every patient deserves a choice–now they are able to choose a non-invasive, out-patient treatment option for non-melanoma skin cancer and keloids.
For more information Click here
Designed with patients and physicians in mind, the SRT-100+™ is compact, mobile, and easy to use. Every patient deserves a choice–now they are able to choose a non-invasive, out-patient treatment option for non-melanoma skin cancer and keloids.
For more information Click here
